Oak Ridge Investments LLC Biogen Inc. Transaction History

Oak Ridge Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $5.51 Million - $7.79 Million	-21,180 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $274,414 - $307,365	-892 Reduced 4.04%	21,180 $6.75 Million
Q3 2017 Nov 07, 2017	SELL	$281.15 - $329.69 $676,446 - $793,234	-2,406 Reduced 9.83%	22,072 $6.91 Million
Q2 2017 Aug 10, 2017	BUY	N/A	24,478	24,478 $6.64 Million

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.